<
News / Press release
Recall of Apo-Acyclovir Tablets 200mg and 800mg
[Hong Kong, 29 July 2022] The Department of Health (DH) today (July 29) endorsed Hind Wing Co Ltd (Hind Wing), to recall a total of three batches of the following two products from the market as a precautionary measure due to the presence of an impurity (N-nitrosodimethylamine) in the products.| Name of product | Hong Kong registration number | Batch number |
| Apo-Acyclovir Tablets 200mg | HK-43427 | TF4466 |
| Apo-Acyclovir Tablets 800mg | HK-58228 | TE5062 TH6119 |
The above affected batches of the products have been imported into Hong Kong and supplied to local doctors, pharmacies and DH clinics.
Hind Wing has set up a dedicated Recall hotline (852 - 2541 5731) to handle related enquiries.
Hind Wing will closely monitor the recall and report to DH as appropriate. So far, Hind Wing has not received any adverse reaction reports in connection with the impacted batches.
Friday, July 29, 2022